Global Antinuclear Antibody Testing Market to Reach $2.4 Billion by 2027
Amid the COVID-19 crisis, the global market for Antinuclear Antibody Testing estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2027, growing at a CAGR of 11.1% over the analysis period 2020-2027. Assay Kits & Reagents, one of the segments analyzed in the report, is projected to record a 11.9% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Systems segment is readjusted to a revised 10.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $307.6 Million, While China is Forecast to Grow at 14.6% CAGR
The Antinuclear Antibody Testing market in the U.S. is estimated at US$307.6 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$516.2 Million by the year 2027 trailing a CAGR of 14.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.7% and 9.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.7% CAGR.
Software & Services Segment to Record 10.5% CAGR
In the global Software & Services segment, USA, Canada, Japan, China and Europe will drive the 9.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$186.8 Million in the year 2020 will reach a projected size of US$359.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$345.1 Million by the year 2027, while Latin America will expand at a 12% CAGR through the analysis period.
Select Competitors (Total 44 Featured):
Amid the COVID-19 crisis, the global market for Antinuclear Antibody Testing estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2027, growing at a CAGR of 11.1% over the analysis period 2020-2027. Assay Kits & Reagents, one of the segments analyzed in the report, is projected to record a 11.9% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Systems segment is readjusted to a revised 10.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $307.6 Million, While China is Forecast to Grow at 14.6% CAGR
The Antinuclear Antibody Testing market in the U.S. is estimated at US$307.6 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$516.2 Million by the year 2027 trailing a CAGR of 14.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.7% and 9.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.7% CAGR.
Software & Services Segment to Record 10.5% CAGR
In the global Software & Services segment, USA, Canada, Japan, China and Europe will drive the 9.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$186.8 Million in the year 2020 will reach a projected size of US$359.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$345.1 Million by the year 2027, while Latin America will expand at a 12% CAGR through the analysis period.
Select Competitors (Total 44 Featured):
- Antibodies Inc.
- Bio-Rad Laboratories, Inc.
- Erba Diagnostics, Inc.
- Euroimmun AG
- Immuno Concepts N.A. Ltd.
- INOVA Diagnostics, Inc.
- Thermo Fisher Scientific, Inc.
- Trinity Biotech PLC
- Zeus Scientific, Inc.
Frequently Asked Questions about the Global Market for Antinuclear Antibody Testing
What is the estimated value of the Global Market for Antinuclear Antibody Testing?
What is the growth rate of the Global Market for Antinuclear Antibody Testing?
What is the forecasted size of the Global Market for Antinuclear Antibody Testing?
Note: Product cover images may vary from those shown
I. METHODOLOGY
II. EXECUTIVE SUMMARY
III. MARKET ANALYSIS
IV. COMPETITION
II. EXECUTIVE SUMMARY
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
III. MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 44
Note: Product cover images may vary from those shown
